erlotinib hydrochloride has been researched along with Acantholytic Dyskeratotic Epidermal Nevi in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, DE; Colozza, S; Okereke, UR | 1 |
1 other study(ies) available for erlotinib hydrochloride and Acantholytic Dyskeratotic Epidermal Nevi
| Article | Year |
|---|---|
A case of new onset keratosis pilaris after discontinuation of erlotinib.
Topics: Abnormalities, Multiple; Antineoplastic Agents; Darier Disease; ErbB Receptors; Erlotinib Hydrochloride; Eyebrows; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Protein Kinase Inhibitors; Quinazolines | 2014 |